![Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinoma]()
Phase II trial of induction irinotecan-cisplatin followed by concurrent irinotecan-cisplatin and radiotherapy for unresectable, locally advanced gastric and oesophageal-gastric junction adenocarcinomaFernando Rivera; Maica Galán; Josep Tabernero; Andres Cervantes; Mª Eugenia Vega-Villegas; Javier Gallego; Berta Laquente; Edith Rodríguez; Alfredo Carrato; Pilar Escudero; Bartomeu Massutí; Vicente Alonso-Orduña; Adelaida Cardenal; Alberto Sáenz; Jordi Giralt; Ana Lucia Yuste; Antonio Antón; Enrique Aranda; On Behalf of the Spanish Cooperative Group for Digestive Tumour Therapy (TTD) · 2011